Innocan Pharma’s LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

HERZLIYA, Israel and CALGARY, Alberta, March 5, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the development of drug …